EQT
57
-3
MS
80
-3
TRV
56
-2
CMG
69
-3
RSG
77
4
PNR
74
5
XRX
34
-3
MRO
46
3
C
62
-3
DOW
30
2
PX
73
-6
KEY
46
-2
NOC
40
-10
MMM
42
5
NI
73
3
CHD
48
-3
ADI
45
-5
PM
58
2
IFF
53
2
VZ
42
3
EQT
57
-3
MS
80
-3
TRV
56
-2
CMG
69
-3
RSG
77
4
PNR
74
5
XRX
34
-3
MRO
46
3
C
62
-3
DOW
30
2
PX
73
-6
KEY
46
-2
NOC
40
-10
MMM
42
5
NI
73
3
CHD
48
-3
ADI
45
-5
PM
58
2
IFF
53
2
VZ
42
3
Financhill
Back

Verrica Pharmaceuticals Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
25

VRCA
Verrica Pharmaceuticals

Last Price:
0.92
Seasonality Move:
34.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Verrica Pharmaceuticals Price Quote

$0.92
+0.08 (+9.13%)
(Updated: November 14, 2024 at 11:50 AM ET)

Verrica Pharmaceuticals Key Stats

Sell
25
Verrica Pharmaceuticals (VRCA) is a Sell
Day range:
$0.83 - $0.93
52-week range:
$0.70 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.67
P/B ratio:
0%
Volume:
342K
Avg. volume:
1.1M
1-year change:
-71.99%
Market cap:
$42.2M
Revenue:
$5.1M
EPS:
$-1.84

How Much Does Verrica Pharmaceuticals Make?

Is Verrica Pharmaceuticals Growing As A Company?

Data Unavailable

Verrica Pharmaceuticals Stock Price Performance

What Is Verrica Pharmaceuticals 52-Week High & Low?

Verrica Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verrica Pharmaceuticals?

Is Verrica Pharmaceuticals Cash Flow Positive?

  • What Is VRCA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$59.4M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.7M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$254K

Verrica Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRCA return on invested capital is -184.44%
  • What Is Verrica Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -128.78%
  • What Is VRCA Return On Equity?
    ROE is a measure of profitability and is -2619.46%

Verrica Pharmaceuticals Earnings Date & Stock Price

Verrica Pharmaceuticals Competitors

Verrica Pharmaceuticals Dividend Yield

Verrica Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.45%
Revenue: 0% -133.85%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 6.33
Upside from Last Price: 651.28%

Major Shareholders

  • How many VRCA shares are owned by institutional investors?
    26.7M VRCA shares are owned by institutional investors
  • How many VRCA shares are owned by insiders?
    11.7M VRCA shares are owned by insiders